Rxstrategies
Pharmacy services/software company that provides services to health care providers.
Based in FL
AI Overview
With $248K in lobbying spend across 18 quarterly filings, Rxstrategies is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $20K |
| 2019 | $88K |
| 2020 | $80K |
| 2021 | $60K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Rxstrategies disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to the federal 340B drug discount program and other matters impacting providers serving low-income and vulnerable populations.
General education on the 340B drug discount program and its importance to healthcare providers, patients, communities and businesses.
Discuss the importance of the 340B drug discount program and related policy areas.
Discuss importance of 340B drug discount program and related policy matters.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.